Imperatives and Strategies for Ethical Advertising in the Nigerian Pharmaceutical Industry: (A Study of Emzor Pharmaceutical Industries Limited)

Abstract

Introduction: The Nigerian pharmaceutical industry is growing with the potentials of doing a lot better than it is presently toward achieving medicines security for the country, but it faces critical challenges regarding ethical advertising practices. Ethical advertising is important to ensure pharmaceutical products are promoted transparently protecting consumers’ health and maintaining trust in the sector. This paper examines the imperatives and strategies for ethical advertising within the Nigerian Pharmaceutical Industry using Emzor Pharmaceutical Industries Limited, a major player in the market as case study. By analyzing Emzor’s advertising practices, this study aims to highlight the current ethical standards, identify challenges and propose strategies for improvement.
Methods: This study employed a two-pronged methodological approach; a review of existing literature and content analysis. The review of literature examined relevant academic articles, regulatory guidelines, and industry reports to establish a theoretical framework for ethical advertising in the pharmaceutical sector. This review provided insights into the regulatory space, industry standards, and best practices for ethical advertising. The content analysis was used to assess the actual advertising materials of Emzor Pharmaceutical Industries Limited. This included print materials, digital and broadcast materials. These were analyzed to examine how well they align with ethical standards in terms of accuracy, transparency and comprehensiveness. By comparing how it stands with recommended guidelines and regulatory requirements the study can gauge the company’s compliance to these standards.
Findings/Discussion: The findings reveal that Emzor Pharmaceuticals Industries Limited demonstrates some commitment to ethical advertising as evidenced by adherence to regulatory guidelines and industry standards. The company advertisements generally provide balanced information about medicine efficacy, safety and side effects. It was observed from the content analysis that 63% reported relatively accurate information about advertised medicines while only 16% reported about the inherent risks associated with the medications. A significant proportion of advertisement materials lacked clarity in conveying potential risks associated with the medications which could mislead consumers or healthcare professionals, as there are no medicines without side effects. The literature review and content analysis showed dire needs for ethical advertising in the Nigerian Pharmaceutical sector and the need for enforcement of regulatory guidelines, the need for transparent and accurate communication, and ongoing training for those involved in company’s promotional activities. Some challenges such as competitive pressures and poor regulatory oversight functions were identified as the problem of the Nigerian pharmaceutical industry.
Conclusion: The study concludes that Emzor Pharmaceutical Industries Limited is largely successful in implementing ethical advertising practices but also faces ongoing challenges common to the industry that require attention. For the wider Nigerian Pharmaceutical Industry, the findings underscore the importance of stringent regulatory oversight and clear ethical guidelines. The findings in the industry highlights the need for a comprehensive approach to ethical advertising, incorporating robust internal controls and continuous professional development of those involved in medications promotional functions. Future research should focus on the effectiveness of regulatory interventions and explore how similar strategies can be applied across the entire spectrum of the Nigerian Pharmaceutical sector to improve overall ethical advertising in the industry.